TY - JOUR
T1 - Prevalence and Causes of Fatal Outcome in Catheter Ablation of Atrial Fibrillation
AU - Cappato, Riccardo
AU - Calkins, Hugh
AU - Chen, Shih Ann
AU - Davies, Wyn
AU - Iesaka, Yoshito
AU - Kalman, Jonathan
AU - Kim, You Ho
AU - Klein, George
AU - Natale, Andrea
AU - Packer, Douglas
AU - Skanes, Allan
N1 - Funding Information:
Dr. Cappato is a consultant and speaker for Biosense Webster and St. Jude Medical, a consultant for Bard, on the Advisory Board for St. Jude Medical, and has received research grants from Biosense Webster, St. Jude Medical, and Bard. Dr. Calkins is a consultant for Ablation Frontiers, Biosense Webster, and Boston Scientific, and has received stock options from Ablation Frontiers, fellowship and research support from Biosense Webster, and lecture support from St. Jude Medical. Dr. Davies is a consultant for Cryocath and Cyberheart. Dr. Kalman has received research grants and fellowship support from St. Jude Medical, Biosense Webster, and Medtronic Inc. Dr. Natale is a speaker for St. Jude Medical and Biosense Webster, and is on the Advisory Board of Biosense Webster, Stereotaxis, and St. Jude Medical. Dr. Packer is a speaker for Biosense Webster, Medtronic, and St. Jude Medical, a consultant for Biosense Webster and Boston Scientific, has received research contracts from Biosense Webster, and is on the Advisory Board of Siemens Medical. Dr. Skanes is on the Physician Advisory Board of and a speaker for Biosense Webster, and has received research grants from Biosense Webster.
PY - 2009/5/12
Y1 - 2009/5/12
N2 - Objectives: The purpose of this study was to provide a systematic multicenter survey on the incidence and causes of death occurring in the setting of or as a consequence of catheter ablation (CA) of atrial fibrillation (AF). Background: CA of AF is considered to be generally safe. However, serious complications, including death, have been reported. Methods: Using a retrospective case series, data relevant to the incidence and cause of intra- and post-procedural death occurring in patients undergoing CA of AF between 1995 and 2006 were collected from 162 of 546 identified centers worldwide. Results: Thirty-two deaths (0.98 per 1,000 patients) were reported during 45,115 procedures in 32,569 patients. Causes of deaths included tamponade in 8 patients (1 later than 30 days), stroke in 5 patients (2 later than 30 days), atrioesophageal fistula in 5 patients, and massive pneumonia in 2 patients. Myocardial infarction, intractable torsades de pointes, septicemia, sudden respiratory arrest, extrapericardial pulmonary vein (PV) perforation, occlusion of both lateral PVs, hemothorax, and anaphylaxis were reported to be responsible for 1 death each, while asphyxia from tracheal compression secondary to subclavian hematoma, intracranial bleeding, acute respiratory distress syndrome, and esophageal perforation from an intraoperative transesophageal echocardiographic probe were causes of 1 late death each. Conclusions: Death is a complication of CA of AF, occurring in 1 of 1,000 patients. Knowledge of possible precipitating causes is key to operators and needs to be considered during decision making with patients.
AB - Objectives: The purpose of this study was to provide a systematic multicenter survey on the incidence and causes of death occurring in the setting of or as a consequence of catheter ablation (CA) of atrial fibrillation (AF). Background: CA of AF is considered to be generally safe. However, serious complications, including death, have been reported. Methods: Using a retrospective case series, data relevant to the incidence and cause of intra- and post-procedural death occurring in patients undergoing CA of AF between 1995 and 2006 were collected from 162 of 546 identified centers worldwide. Results: Thirty-two deaths (0.98 per 1,000 patients) were reported during 45,115 procedures in 32,569 patients. Causes of deaths included tamponade in 8 patients (1 later than 30 days), stroke in 5 patients (2 later than 30 days), atrioesophageal fistula in 5 patients, and massive pneumonia in 2 patients. Myocardial infarction, intractable torsades de pointes, septicemia, sudden respiratory arrest, extrapericardial pulmonary vein (PV) perforation, occlusion of both lateral PVs, hemothorax, and anaphylaxis were reported to be responsible for 1 death each, while asphyxia from tracheal compression secondary to subclavian hematoma, intracranial bleeding, acute respiratory distress syndrome, and esophageal perforation from an intraoperative transesophageal echocardiographic probe were causes of 1 late death each. Conclusions: Death is a complication of CA of AF, occurring in 1 of 1,000 patients. Knowledge of possible precipitating causes is key to operators and needs to be considered during decision making with patients.
KW - atrial fibrillation
KW - catheter ablation
KW - pulmonary vein
KW - radiofrequency
KW - supraventricular
UR - http://www.scopus.com/inward/record.url?scp=65349117063&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=65349117063&partnerID=8YFLogxK
U2 - 10.1016/j.jacc.2009.02.022
DO - 10.1016/j.jacc.2009.02.022
M3 - Article
C2 - 19422987
AN - SCOPUS:65349117063
SN - 0735-1097
VL - 53
SP - 1798
EP - 1803
JO - Journal of the American College of Cardiology
JF - Journal of the American College of Cardiology
IS - 19
ER -